10 insights to tackle vaccine hesitancy driven by misinformation on social media

Effective population level vaccination campaigns are fundamental to public health. Countercampaigns, which are as old as the first vaccines, can disrupt uptake and threaten public health globally.

Novel bladder cancer treatment gains MHRA approval in the UK

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the

November 9, 2024

Just how low did the government go with first IRA offers? Pharma’s not telling

Medicare price negotiations under the Inflation Reduction Act have officially kicked off, but pharma companies with drugs on the list are keeping quiet about CMS’

February 2, 2024

SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE 02.05.2024 / 08:00 CET/CEST The

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.